Indium photosensitizers for pdt
CA 2336306 A1 · Owner: Miravant Pharmaceuticals, Inc. · Inventors: Robinson, Byron C.; Phadke, Avinash S.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention disclosed herein involves a phototherapeutic pyrrolic core complexed with a non-radioactive Indium atom. Complexation of Indium by the pyrrolic core forms a metalopyrrolic compound which influences enables these compounds to localize at target sites a phototherapy. Such functionally aids in both detection and phototherapy of disease sites or provides functionality , that binds to site specific receptors of a target area such that the therapy is improved.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 29, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 29, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 29, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.